Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11873309 Heterocyclic compounds as immunomodulators

Patent 11873309 was granted and assigned to Incyte on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kaijiong Xiao0

Fenglei Zhang0

Wenqing Yao0

Liangxing Wu0

Date of Patent

January 16, 2024

0

Patent Application Number

169528720

Date Filed

November 19, 2020

0

Patent Citations

US Patent 7691870 Benzimidazole carboxamides as raf kinase inhibitors

0

US Patent 7851489 Pyridinone compounds

0

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

0

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

0

US Patent 8163743 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases

0

US Patent 8168757 PD-1 binding proteins

0

US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

0

US Patent 8541424 Anti-viral compounds

0

...

Patent Primary Examiner

Brian E McDowell

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11873309 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool